
Jacky Yuen
Examiner (ID: 1754, Phone: (571)270-5749 , Office: P/1735 )
| Most Active Art Unit | 1735 |
| Art Unit(s) | 1735, 1793 |
| Total Applications | 685 |
| Issued Applications | 222 |
| Pending Applications | 70 |
| Abandoned Applications | 404 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17913234
[patent_doc_number] => 20220315629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => GRIFFITHSIN MUTANTS
[patent_app_type] => utility
[patent_app_number] => 17/724342
[patent_app_country] => US
[patent_app_date] => 2022-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9038
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17724342
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/724342 | Griffithsin mutants | Apr 18, 2022 | Issued |
Array
(
[id] => 19572151
[patent_doc_number] => 20240376443
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-14
[patent_title] => NOVEL PROTEIN HAVING METHANE OXIDATION ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 18/288490
[patent_app_country] => US
[patent_app_date] => 2022-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4871
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18288490
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/288490 | NOVEL PROTEIN HAVING METHANE OXIDATION ACTIVITY | Apr 14, 2022 | Pending |
Array
(
[id] => 18077741
[patent_doc_number] => 20220403353
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => ENGINEERED POLYMERASES
[patent_app_type] => utility
[patent_app_number] => 17/705043
[patent_app_country] => US
[patent_app_date] => 2022-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 75029
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 283
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17705043
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/705043 | Engineered polymerases | Mar 24, 2022 | Issued |
Array
(
[id] => 18077739
[patent_doc_number] => 20220403351
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => ENGINEERED POLYMERASES
[patent_app_type] => utility
[patent_app_number] => 17/705011
[patent_app_country] => US
[patent_app_date] => 2022-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 74716
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17705011
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/705011 | ENGINEERED POLYMERASES | Mar 24, 2022 | Pending |
Array
(
[id] => 19884362
[patent_doc_number] => 12270056
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-08
[patent_title] => Engineered polymerases
[patent_app_type] => utility
[patent_app_number] => 17/705020
[patent_app_country] => US
[patent_app_date] => 2022-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 50
[patent_no_of_words] => 74716
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17705020
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/705020 | Engineered polymerases | Mar 24, 2022 | Issued |
Array
(
[id] => 18988092
[patent_doc_number] => 20240060061
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => DNASE VARIANTS
[patent_app_type] => utility
[patent_app_number] => 18/547525
[patent_app_country] => US
[patent_app_date] => 2022-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29112
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18547525
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/547525 | DNASE VARIANTS | Mar 9, 2022 | Pending |
Array
(
[id] => 17852247
[patent_doc_number] => 20220282289
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => RECOMBINANT MICROORGANISMS AND USES THEREFOR
[patent_app_type] => utility
[patent_app_number] => 17/653913
[patent_app_country] => US
[patent_app_date] => 2022-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19355
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17653913
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/653913 | RECOMBINANT MICROORGANISMS AND USES THEREFOR | Mar 7, 2022 | Abandoned |
Array
(
[id] => 19060396
[patent_doc_number] => 11939606
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-26
[patent_title] => CRISPR-associated (Cas) protein
[patent_app_type] => utility
[patent_app_number] => 17/678369
[patent_app_country] => US
[patent_app_date] => 2022-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 24186
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17678369
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/678369 | CRISPR-associated (Cas) protein | Feb 22, 2022 | Issued |
Array
(
[id] => 18701583
[patent_doc_number] => 11788082
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-17
[patent_title] => T4 DNA ligase variants with increased thermostability
[patent_app_type] => utility
[patent_app_number] => 17/677655
[patent_app_country] => US
[patent_app_date] => 2022-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 8667
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17677655
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/677655 | T4 DNA ligase variants with increased thermostability | Feb 21, 2022 | Issued |
Array
(
[id] => 18583162
[patent_doc_number] => 20230265421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => TYPE II CRISPR/CAS9 GENOME EDITING SYSTEM AND THE APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/676546
[patent_app_country] => US
[patent_app_date] => 2022-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9081
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17676546
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/676546 | Type II CRISPR/Cas9 genome editing system and the application thereof | Feb 20, 2022 | Issued |
Array
(
[id] => 18461629
[patent_doc_number] => 11685913
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-06-27
[patent_title] => T4 DNA ligase variants with increased resistance to salt
[patent_app_type] => utility
[patent_app_number] => 17/675278
[patent_app_country] => US
[patent_app_date] => 2022-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8075
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17675278
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/675278 | T4 DNA ligase variants with increased resistance to salt | Feb 17, 2022 | Issued |
Array
(
[id] => 17642334
[patent_doc_number] => 20220170072
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => PROGRAMMABLE DNA-GUIDED ARTIFICIAL RESTRICTION ENZYMES
[patent_app_type] => utility
[patent_app_number] => 17/673279
[patent_app_country] => US
[patent_app_date] => 2022-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14692
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17673279
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/673279 | PROGRAMMABLE DNA-GUIDED ARTIFICIAL RESTRICTION ENZYMES | Feb 15, 2022 | Abandoned |
Array
(
[id] => 20179724
[patent_doc_number] => 20250263682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-21
[patent_title] => ALPHA-AMYLASE VARIANTS
[patent_app_type] => utility
[patent_app_number] => 18/263339
[patent_app_country] => US
[patent_app_date] => 2022-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 75552
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18263339
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/263339 | ALPHA-AMYLASE VARIANTS | Feb 10, 2022 | Pending |
Array
(
[id] => 19441457
[patent_doc_number] => 12091699
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-17
[patent_title] => Method for enhancing production of homeoprotein using inhibitor of lysosomal function
[patent_app_type] => utility
[patent_app_number] => 17/586234
[patent_app_country] => US
[patent_app_date] => 2022-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5274
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17586234
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/586234 | Method for enhancing production of homeoprotein using inhibitor of lysosomal function | Jan 26, 2022 | Issued |
Array
(
[id] => 19051199
[patent_doc_number] => 20240093168
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => TRANSCRIPTIONAL PRODUCT IN CELLS OF ORGANISM INCLUDING HUMAN, TRANSFECTED RNA, AND TOOL FOR PURIFYING COMPLEX THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/260452
[patent_app_country] => US
[patent_app_date] => 2022-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9887
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18260452
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/260452 | TRANSCRIPTIONAL PRODUCT IN CELLS OF ORGANISM INCLUDING HUMAN, TRANSFECTED RNA, AND TOOL FOR PURIFYING COMPLEX THEREOF | Jan 3, 2022 | Pending |
Array
(
[id] => 18996205
[patent_doc_number] => 11913038
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-27
[patent_title] => Engineered polymerases for improved sequencing
[patent_app_type] => utility
[patent_app_number] => 17/564500
[patent_app_country] => US
[patent_app_date] => 2021-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 24922
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17564500
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/564500 | Engineered polymerases for improved sequencing | Dec 28, 2021 | Issued |
Array
(
[id] => 18916883
[patent_doc_number] => 11879154
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-23
[patent_title] => Preparation method of high-stability superoxide dismutase with transmembrane capability
[patent_app_type] => utility
[patent_app_number] => 17/563794
[patent_app_country] => US
[patent_app_date] => 2021-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 17
[patent_no_of_words] => 4970
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 212
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17563794
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/563794 | Preparation method of high-stability superoxide dismutase with transmembrane capability | Dec 27, 2021 | Issued |
Array
(
[id] => 18988089
[patent_doc_number] => 20240060058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => Modified DNA Polymerase
[patent_app_type] => utility
[patent_app_number] => 18/259225
[patent_app_country] => US
[patent_app_date] => 2021-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14012
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18259225
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/259225 | Modified DNA Polymerase | Dec 23, 2021 | Abandoned |
Array
(
[id] => 18987890
[patent_doc_number] => 20240059859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => NOVEL PROTEASES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/270248
[patent_app_country] => US
[patent_app_date] => 2021-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15089
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18270248
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/270248 | NOVEL PROTEASES AND USES THEREOF | Dec 20, 2021 | Abandoned |
Array
(
[id] => 17627558
[patent_doc_number] => 20220162573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => POLYMERASE COMPOSITIONS, METHODS OF MAKING AND USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/645146
[patent_app_country] => US
[patent_app_date] => 2021-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59041
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17645146
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/645146 | Polymerase compositions, methods of making and using same | Dec 19, 2021 | Issued |